Top Institutions in Infectious Diseases and Hospital-Acquired Infection Prevention
Leading institutions in this area typically conduct large-scale clinical trials, implement multidisciplinary infection control programs, and integrate oral hygiene interventions into hospital care protocols. They also contribute to guideline development and perform epidemiological surveillance of hospital-acquired infections.
-
#1
Johns Hopkins Hospital
Baltimore, MD
Johns Hopkins leads in hospital-acquired infection research with extensive clinical trials on pneumonia prevention and robust infection control programs integrating oral hygiene measures.
Key Differentiators
- Infectious Diseases
- Hospital Epidemiology
- Pulmonology
-
#2
Mayo Clinic
Rochester, MN
Mayo Clinic conducts multidisciplinary research on hospital-acquired infections and implements comprehensive oral hygiene programs in inpatient settings to reduce pneumonia incidence.
Key Differentiators
- Infectious Diseases
- Pulmonology
- Critical Care Medicine
-
#3
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF is recognized for its research in hospital infection control and has implemented oral care protocols as part of its pneumonia prevention initiatives in acute care settings.
Key Differentiators
- Infectious Diseases
- Hospital Epidemiology
- Pulmonology
-
#4
Imperial College London
London, N/A
Imperial College has a strong focus on hospital-acquired infection epidemiology and prevention, including clinical trials assessing oral hygiene interventions in hospitalized patients.
Key Differentiators
- Infectious Diseases
- Epidemiology
- Critical Care
-
#5
University of Sydney
Sydney, NSW
As the site of the HAPPEN study, University of Sydney has demonstrated leadership in clinical research on oral hygiene to prevent NV-HAP and translating findings into practice.
Key Differentiators
- Infectious Diseases
- Public Health
- Hospital Epidemiology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.
References
- B Mitchell et al, “The hospital acquired pneumonia prevention (HAPPEN) study: a multi-centre randomised controlled trial” (2026). Study presented at ESCMID Global, April 20, 2026, Munich, Germany.
